Loading organizations...
Cianna Medical: Medical device company developing and marketing SAVI and SCOUT for early-stage breast cancer treatment and surgical guidance.
Aliso Viejo, California-based Cianna Medical is a medical device company that develops and manufactures treatments and surgical guidance systems for early-stage breast cancer. The organization primarily supplies hospitals and healthcare providers with the SAVI brachytherapy applicator for post-lumpectomy radiation and the SCOUT wire-free breast localization system. Under the leadership of Chief Executive Officer Jill Anderson, the company secured a $10 million senior credit facility from GE Capital and grew its executive team to 11 members. In 2018, Merit Medical Systems, led by Fred Lampropoulos, acquired the business for an upfront payment of $135 million and up to $65 million in potential earn-outs. At the time of the transaction, the SCOUT device had completed over 45,000 wire-free localizations and was projected to generate $29 million in annual sales. Cianna Medical was originally founded in 2007.
Cianna Medical has raised $49.0M across 6 funding rounds.
Cianna Medical has raised $49.0M in total across 6 funding rounds.
Cianna Medical is a medical device company specializing in innovative technologies for women's health, particularly focused on the treatment of early-stage breast cancer. The company develops products such as the SAVI breast brachytherapy applicator and the SCOUT radar localization system, which enable precise radiation delivery and tissue targeting during lumpectomy and biopsy procedures. These technologies improve surgical accuracy, reduce patient anxiety, and enhance treatment outcomes for breast cancer patients. Cianna Medical serves healthcare providers and patients by addressing challenges in breast cancer surgery and radiation therapy, showing strong clinical validation and adoption momentum[1][2][3][5].
Founded in 2007, Cianna Medical emerged from a need to improve breast cancer treatment through less invasive, more precise radiation and localization methods. The founders, with backgrounds in medical technology and oncology, developed the SAVI applicator to offer an alternative to whole breast irradiation, enabling targeted brachytherapy with excellent local control and cosmetic results. Early pivotal moments include FDA clearances for their products and recognition such as the 2016 Scientific Impact Award from the Society of Breast Surgeons, validating the clinical utility of their technologies[1][2].
Cianna Medical rides the trend of precision medicine and minimally invasive cancer treatments, leveraging advances in imaging, localization, and radiation delivery. The shift away from wire-guided localization to radar and RFID-based systems reflects a broader move toward improving patient comfort and surgical efficiency. Regulatory approvals and growing clinical evidence support wider adoption, while the increasing incidence of breast cancer globally drives demand for innovative treatment options. Cianna Medical influences the ecosystem by setting new standards in breast cancer care technology and fostering integration between surgical oncology and radiation therapy[1][2][3].
Looking ahead, Cianna Medical is poised to expand its impact by advancing next-generation localization and brachytherapy technologies, potentially incorporating AI-assisted imaging and further improving treatment personalization. Trends such as non-wire localization and outpatient cancer care will shape their product development and market growth. As breast cancer treatment evolves toward more patient-centered and precise approaches, Cianna Medical’s technologies are likely to become increasingly integral to standard care protocols, enhancing outcomes and quality of life for patients worldwide[1][3][5].
Cianna Medical has raised $49.0M in total across 6 funding rounds.
Cianna Medical's investors include Brett Haring, Norwest Venture Partners, Neil Bonnano, Heath Lukatch, Emergent Medical Partners, Nancy Olson, Zack Scott, Fog City Fund, Mitsubishi Corporation, Saints Capital, Windamere Venture Partners.
Cianna Medical has raised $49.0M across 6 funding rounds. Most recently, it raised $4.0M Debt in July 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 14, 2015 | $4.0M Debt | Brett Haring | |
| Jun 1, 2015 | $4.0M Series U | Norwest Venture Partners | |
| May 22, 2014 | $10.0M Debt | Neil Bonnano | |
| Apr 1, 2011 | $12.0M Series B | Heath Lukatch | Norwest Venture Partners, Emergent Medical Partners, Nancy Olson, Zack Scott |
| Apr 7, 2009 | $10.0M Series B | Emergent Medical Partners, Fog City Fund, Mitsubishi Corporation, Saints Capital | |
| Feb 27, 2008 | $9.0M Series A | Fog City Fund, Windamere Venture Partners |